Fig. 1From: Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle Easta, overall and event free survival of entire group. b, event free survival with stage I-II and stage III-IV. c, event free survival with stage I, II, III and IV. d, event free survival according to the German Hodgkin Study Group risk models; early favorable, early unfavorable and advancedBack to article page